Interim data from Wave Life Sciences' INLIGHT trial showed promising results for WVE-007, an investigational treatment for obesity.

A new WHO guideline on GLP-1s and recent efforts to reduce the drugs’ costs now and going forward are unlikely to change US ...

Body Mass Index (BMI) is a key tool for assessing weight categories and potential health risks, estimating body fat based on ...

A new study published in The Journal of Nutrition showed that in people who are overweight or obese, consuming 25 g of pea ...

(HealthDay News) — Abdominal obesity is associated with more harmful changes to heart structure than body weight alone, according to a study presented at the annual meeting of the Radiological Society ...

Increases in levels of blood biomarkers of Alzheimer disease seen over time for all participants, with faster rates of increase for individuals with obesity.

Mild calorie restriction was associated with favorable reductions in cardiometabolic risk factors among older adults with obesity and overweight.

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

Roughly 1 million American kids became obese during the COVID-19 pandemic, a new study says. Childhood obesity rates in the U ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...

Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...

In public health and in clinical practice, terms matter. Not because they change the biology, but because they shape how ...